Europe drives Swedencare growth in first quarter: full analysis
Swedencare’s first-quarter 2026 results suggest Europe is becoming more than a supporting market for the pet health company. While total Q1 revenue rose just 1% year over year to SEK 650.3 million, the underlying picture was stronger: organic, currency-adjusted growth reached 11%, and Europe stood out with 38% revenue growth to SEK 153.8 million. That lifted Europe’s share of group revenue to 24%, up from 17% in the same quarter last year. (swedencare.com)
The shift has been building for some time. In 2024, Swedencare was already signaling that Europe was becoming a larger part of its mix, with management highlighting plans to bring more US brands into the region, expand local brands, and strengthen online partnerships. The company’s March 24, 2025 announcement that it would acquire Summit Veterinary Pharmaceuticals, followed by closing on April 1, 2025, added a veterinary-focused foothold in the UK animal health specials market. Swedencare said at the time that Summit served veterinary professionals and offered expansion potential into the EU and other markets. (globalpetindustry.com)
In the new Q1 report, Swedencare attributed group organic growth mainly to its dental and pharma product groups. February’s “Dental Month” supported sales, and ProDen PlaqueOff, now described by the company as its largest brand by revenue, remained a key contributor. In Europe, the dental category was the fastest-growing product group, helped by Amazon UK sales and broader online demand. The production segment also posted 23% organic growth, with pharma revenue nearly doubling year over year on stronger development projects and production volumes. (storage.mfn.se)
Europe’s quarter also reflected both acquisition and channel effects. Swedencare said Summit contributed SEK 26.0 million in Q1 revenue, accounting for a sizable part of the region’s 23% acquired growth. The rest came from organic gains across all companies in the segment, according to the report. Management also pointed to a limited European launch of NaturVet on Amazon and Zooplus, with a full-scale launch planned later in 2026. In parallel, the company launched ProDen PlaqueOff Crème for cats in Europe at the end of the quarter, using a phased distribution strategy before a broader rollout later this year. (storage.mfn.se)
Industry and investor commentary around the quarter has focused on execution rather than headline growth. Swedencare’s earnings-call materials indicated that margins and sales were still being affected by the NaturVet Amazon transition, which the company has been managing in-house since April 2025, and by related external costs tied to Amazon sales. Even so, management signaled confidence that the Amazon setup should support stronger European online sales through the rest of 2026. (storage.mfn.se)
Why it matters: For veterinary professionals, this quarter is less about a single blockbuster launch and more about how a supplier is reshaping its growth model. Swedencare’s expansion in Europe combines veterinary-facing assets like Summit with consumer-facing growth through Amazon, Zooplus, and branded oral care. That matters because it can change where pet parents encounter products first, how quickly new SKUs scale across markets, and how competitors position dental, dermatology, supplement, and compounded or specialty offerings. The Summit deal is particularly notable for clinics because it brings Swedencare deeper into products sold exclusively to veterinary professionals, not just retail and e-commerce channels. (storage.mfn.se)
There’s also a broader signal in the numbers: Europe is no longer just a diversification story for Swedencare. With 21% organic growth in the region, versus 5% in North America, Europe is increasingly where the company appears to be testing launches, building online traction, and integrating acquisitions into a more veterinary-relevant platform. That could make the region a bellwether for future product commercialization and channel strategy. This is an inference based on the company’s segment trends and launch activity, rather than a direct company statement. (storage.mfn.se)
What to watch: The next milestones are likely to be the broader European rollout of NaturVet, the full launch of ProDen PlaqueOff Crème for cats later in 2026, and whether Summit continues to add organic momentum after it moves fully into the comparison base beginning in Q2 2026. Swedencare’s next scheduled report is its Q2 half-year report on July 22, 2026. (storage.mfn.se)